Benzinga

Benzinga

Benzinga

martedì, settembre 01

Quoin Pharmaceuticals Ltd

QNRXNASDAQ
Trade with Public
Trade with Public
$5.81
-0.41-6.59%
Ult. Agg.: Sep 1, 9:29 AM
PanoramicaNotiziePrevisioni utiliObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaRapporto azionario

Quoin Pharmaceuticals Analyst Price Targets

Wall Street analyst price targets and consensus rating for Quoin Pharmaceuticals (QNRX).

Price Target Range — 2 Quarters

Analyst Consensus — 2 Analysts

2Buy
Consensus RatingBuy# Analysts2Avg. Consensus PT$17Upside to Avg. PT+192.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
May 4, 2026LUCID CAPITAL MARKETSDev Prasad InitiateBuy$30
Mar 15, 2024Maxim GroupNaz RahmanPT CutBuy$15→$4

Analyst Ratings News

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $30

LUCID CAPITAL MARKETS analyst Dev Prasad initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $30.
Benzinga Newsdesk

Maxim Group Maintains Buy Rating for Quoin Pharmaceuticals: Here's What You Need To Know

Benzinga Insights

PRO
Maxim Group Maintains Buy on Quoin Pharmaceuticals, Lowers Price Target to $4

Maxim Group analyst Naz Rahman maintains Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy and lowers the price target from $15 to $4.
Benzinga Newsdesk

Watching Quoin Pharmaceuticals; Zacks Small-Cap Research Sets $4 Price Target

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_03222023_QNRX_Marin.pdf
Happy Mohamed

Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022

Upgrades
Benzinga Insights

PRO
Alliance Global Partners Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $20

Alliance Global Partners analyst James Molloy initiates coverage on Quoin Pharmaceuticals (NASDAQ:QNRX) with a Buy rating and announces Price Target of $20.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved